Inside the autumn of Vinay Prasad, the FDA’s prime vaccine official
Vinay Prasad had an issue. A number of, really. His employees on the Meals and Drug Administration saved leaking to the press. He was underneath assault by President Trump’s allies after shifting to drag a gene remedy off the market. Democrats weren’t comfortable together with his Covid vaccine restrictions, and anti-vaccine advocates had been lambasting him for approving the pictures in any respect.
He despatched off an electronic mail, obtained by STAT, to his group on Saturday night, making an attempt to manage the backlash. The company’s latest crackdown on the gene remedy product was pushed by a scientific consensus, he stated. Not simply him.
“The motivation is solely what we expect is within the public curiosity— the correct judgment of advantages and dangers,” Prasad wrote.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
